TLOG (TetraLogic Pharmaceuticals) Market Cap: $0.00 Mil (As of Jul. 07, 2026)


What is TetraLogic Pharmaceuticals Market Cap?

TetraLogic Pharmaceuticals TLOG Market Cap is $0.00 Mil as of Jul. 07, 2026.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). TetraLogic Pharmaceuticals's share price for the quarter that ended in Sep. 2016 was $0.1575. TetraLogic Pharmaceuticals's Shares Outstanding (EOP) for the quarter that ended in Sep. 2016 was 24.77 Mil. Therefore, TetraLogic Pharmaceuticals's market cap for the quarter that ended in Sep. 2016 was $3.90 Mil.

TetraLogic Pharmaceuticals's quarterly market cap increased from Mar. 2016 ($4.40 Mil) to Jun. 2016 ($7.58 Mil) but then declined from Jun. 2016 ($7.58 Mil) to Sep. 2016 ($3.90 Mil).

TetraLogic Pharmaceuticals's annual market cap declined from Dec. 2013 ($211.33 Mil) to Dec. 2014 ($107.65 Mil) and declined from Dec. 2014 ($107.65 Mil) to Dec. 2015 ($42.85 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. TetraLogic Pharmaceuticals's Enterprise Value for Today is $0.00 Mil.

TetraLogic Pharmaceuticals  (OTCPK:TLOG) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

TetraLogic Pharmaceuticals Market Cap Related Terms

TetraLogic Pharmaceuticals Market Cap Historical Data

* Premium members only.

The historical data trend for TetraLogic Pharmaceuticals's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TetraLogic Pharmaceuticals Market Cap Chart

TetraLogic Pharmaceuticals Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15
Market Cap
0.00 0.00 211.33 107.65 42.85

TetraLogic Pharmaceuticals Quarterly Data
Dec11 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 45.82 42.85 4.40 7.58 3.90

TLOG vs ARGSQ, GTHR, SOAN: Market Cap Comparison

For the Biotechnology subindustry, TetraLogic Pharmaceuticals's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TetraLogic Pharmaceuticals Market Cap vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TetraLogic Pharmaceuticals's Market Cap distribution charts can be found below:

* The bar in red indicates where TetraLogic Pharmaceuticals's Market Cap falls into.


TetraLogic Pharmaceuticals Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

TetraLogic Pharmaceuticals's Market Cap for the fiscal year that ended in Dec. 2015 is calculated as

Market Cap (A: Dec. 2015 )=Share Price (A: Dec. 2015 )*Shares Outstanding (EOP) (A: Dec. 2015 )
=$1.73*24.769
=$42.85

TetraLogic Pharmaceuticals's Market Cap for the quarter that ended in Sep. 2016 is calculated as

Market Cap (Q: Sep. 2016 )=Share Price (Q: Sep. 2016 )*Shares Outstanding (EOP) (Q: Sep. 2016 )
=$0.1575*24.769
=$3.90

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of $0.00 Mil mean?
TetraLogic Pharmaceuticals (TLOG) has a Market Cap of $0.00 Mil as of Jul. 07, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on TetraLogic Pharmaceuticals and its competitors.
Is TetraLogic Pharmaceuticals' Market Cap too high?
TetraLogic Pharmaceuticals' current Market Cap is $0.00 Mil.
How does TetraLogic Pharmaceuticals' Market Cap compare to ARGSQ and GTHR?
TetraLogic Pharmaceuticals' Market Cap of $0.00 Mil can be compared against companies in the Biotechnology industry. The industry median Market Cap is 121.57. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 121.57, based on 1,421 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on TetraLogic Pharmaceuticals and its competitors. For the Biotechnology industry, the median Market Cap is 121.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TetraLogic Pharmaceuticals's current Market Cap is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TetraLogic Pharmaceuticals stock overvalued right now?
TetraLogic Pharmaceuticals (TLOG) has a current Market Cap of $0.00 Mil. The current Market Cap is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For TetraLogic Pharmaceuticals (TLOG), the current Market Cap is $0.00 Mil as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TetraLogic Pharmaceuticals Business Description

Address 343 Phoenixville Pike, Malvern, PA, USA, 19355
TetraLogic Pharmaceuticals Corp is a biopharmaceutical company. The company is engaged in developing novel small molecule therapeutics in oncology.